1-3 of 3
Arun P. Wiita
Close
Sort by
Journal Articles

FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma

Austin B. Bigley, Shanae Spade, Nadia H. Agha, Sujit Biswas, Suni Tang, Muhammad H. Malik, Lu Dai, Shalaleh Masoumi, Bonell Patiño-Escobar, Martina Hale, Guy DiPierro, Ronald Martell, Byron Hann, Nina Shah, Arun P. Wiita, Xinli Liu
Journal: Blood Advances
Blood Adv (2021) 5 (15): 3021–3031.
https://doi.org/10.1182/bloodadvances.2020002440
Published: 2021
Includes: Supplemental data
Journal Articles

CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma

Poornima Ramkumar, Anthony B. Abarientos, Ruilin Tian, Meghan Seyler, Jaime T. Leong, Merissa Chen, Priya Choudhry, Torsten Hechler, Nina Shah, Sandy W. Wong, Thomas G. Martin, III, Jeffrey L. Wolf, Kole T. Roybal, Andreas Pahl, Jack Taunton, Arun P. Wiita, Martin Kampmann
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2899–2911.
https://doi.org/10.1182/bloodadvances.2019001346
Published: 2020
Includes: Supplemental data
Journal Articles

Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma

Yu-Hsiu T. Lin, Gregory P. Way, Benjamin G. Barwick, Margarette C. Mariano, Makeba Marcoulis, Ian D. Ferguson, Christoph Driessen, Lawrence H. Boise, Casey S. Greene, Arun P. Wiita
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3214–3227.
https://doi.org/10.1182/bloodadvances.2019000303
Published: 2019
Includes: Supplemental data